FIKCX
Price
$60.40
Change
+$0.14 (+0.23%)
Updated
Jul 8 closing price
Net Assets
3.35B
THISX
Price
$76.70
Change
-$0.00 (-0.00%)
Updated
Jul 8 closing price
Net Assets
11.14B
Interact to see
Advertisement

FIKCX vs THISX

Header iconFIKCX vs THISX Comparison
Open Charts FIKCX vs THISXBanner chart's image
Fidelity Advisor Health Care Z
Price$60.40
Change+$0.14 (+0.23%)
VolumeN/A
Net Assets3.35B
T. Rowe Price Health Sciences I
Price$76.70
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets11.14B
FIKCX vs THISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FIKCX vs. THISX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIKCX is a Buy and THISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
THISX has more cash in the bank: 11.1B vs. FIKCX (3.35B). THISX pays higher dividends than FIKCX: THISX (0.18) vs FIKCX (0.00). FIKCX was incepted earlier than THISX: FIKCX (7 years) vs THISX (9 years). THISX (0.67) is less costly to investors than FIKCX (0.56). THISX is a more actively managed with annual turnover of: 52.40 vs. FIKCX (37.00). FIKCX has a lower initial minimum investment than THISX: FIKCX (0) vs THISX (500000). FIKCX annual gain was more profitable for investors over the last year : -13.09 vs. THISX (-19.17). FIKCX return over 5 years is better than : -8.51 vs. THISX (-13.79).
FIKCXTHISXFIKCX / THISX
Total Expense Ratio0.560.6784%
Annual Report Gross Expense Ratio0.560.6784%
Fund Existence7 years9 years-
Gain YTD-4.531-3.776120%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.35B11.1B30%
Annual Yield % from dividends0.000.18-
Returns for 1 year-13.09-19.1768%
Returns for 3 years-3.15-13.9623%
Returns for 5 years-8.51-13.7962%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEQAX8.64N/A
N/A
Oaktree Emerging Markets Equity A
DDVAX14.13N/A
N/A
Macquarie Value A
VCGEX6.99N/A
N/A
VALIC Company I Emerg Economies
ACEKX10.90N/A
N/A
Invesco Equity and Income R5
JLGAX20.68-0.16
-0.77%
JAG Large Cap Growth A